tiprankstipranks
CNS Non-Executive Chair Increases Shareholding
Company Announcements

CNS Non-Executive Chair Increases Shareholding

Story Highlights

Maximize Your Portfolio with Data Driven Insights:

  • Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
  • Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio

Omega Diagnostics ( (GB:CNSL) ) just unveiled an update.

Cambridge Nutritional Sciences plc announced that Carolyn Rand, the Non-Executive Chair, has purchased 100,000 ordinary shares at 3.59 pence each on February 5, 2025. This acquisition increases her total beneficial holding to 197,500 shares, representing approximately 0.08% of the company’s issued share capital, potentially indicating confidence in the company’s future prospects.

More about Omega Diagnostics

Cambridge Nutritional Sciences plc is a specialist medical diagnostics company focused on promoting a personalized and functional approach to health and nutrition, with industry-leading health and nutrition products.

YTD Price Performance: 25.45%

Average Trading Volume: 480,802

Technical Sentiment Consensus Rating: Hold

Current Market Cap: £8.21M

See more data about CNSL stock on TipRanks’ Stock Analysis page.

Related Articles
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App